IMAGES

  1. Gene expression patterns and immune signatures associated with dengue

    dengue fever research articles

  2. Improving data for dengue

    dengue fever research articles

  3. Dengue Fever Facts

    dengue fever research articles

  4. Dengue and Dengue Hemorrhagic Fever, 2nd Edition PDF

    dengue fever research articles

  5. Dengue fever could be eradicated in hot countries by infecting

    dengue fever research articles

  6. Reliably detecting dengue fever

    dengue fever research articles

COMMENTS

  1. Dengue virus: A global human threat: Review of literature

    Dengue is an acute viral illness caused by RNA virus of the family Flaviviridae and spread by Aedes mosquitoes. Presenting features may range from asymptomatic fever to dreaded complications such as hemorrhagic fever and shock. A cute-onset high fever, muscle and joint pain, myalgia, cutaneous rash, hemorrhagic episodes, and circulatory shock ...

  2. Dengue infection: Global importance, immunopathology and management

    In addition, dengue fever may present with extended and unusual manifestations affecting any organ, including the heart, liver, kidney and brain. Studies on vaccine development and vector control are ongoing to prevent this infection of global importance. In this article, the clinicopathological features and management aspects of dengue are ...

  3. Dengue fever: the impact of increasing temperatures and heatwaves

    Dengue, or dengue fever, is a disease caused by infection with the dengue virus (DENV), a member of the Flavivirus genus (Flaviviridae) that also includes yellow fever and Japanese encephalitis. Milder cases can range from asymptomatic to clinical manifestations that include high fever, severe headaches, retro-orbital pain, joint and muscle pains, vomiting and rash. DENV is classified into ...

  4. Dengue: A Growing Problem With New Interventions

    Dengue is the disease caused by 1 of 4 distinct, but closely related dengue viruses (DENV-1-4) that are transmitted by Aedes spp. mosquito vectors. It is the most common arboviral disease worldwide, with the greatest burden in tropical and sub-tropical regions. In the absence of effective prevention and control measures, dengue is projected to increase in both disease burden and geographic ...

  5. Dengue

    Dengue, caused by four closely related viruses, is a growing global public health concern, with outbreaks capable of overwhelming health-care systems and disrupting economies. Dengue is endemic in more than 100 countries across tropical and subtropical regions worldwide, and the expanding range of the mosquito vector, affected in part by climate change, increases risk in new areas such as ...

  6. Recent advances in understanding dengue

    In adults, primary dengue 1 and 3 infections result in high rates of classic dengue fever but dengue 2 and 4 infections cause milder disease and are often ... Dengue hemorrhagic fever in infants: research opportunities ignored. Emerg Infect Dis. 2002; 8 (12):1474-9. 10.3201/eid0812.020170 [PMC free article] [Google Scholar] 15. ...

  7. Management of Dengue: An Updated Review

    The WHO, in 1997, classified symptomatic dengue infections into three categories: undifferentiated fever, dengue fever (DF), and dengue hemorrhagic fever (DHF) . ... Future Research Questions. While relentless research over the past few decades has greatly improved the outcomes of dengue, many pertinent questions still remain unanswered. ...

  8. Dengue

    Patients were previously classified as having either dengue fever or dengue hemorrhagic fever, with the latter classified as grade 1, 2, 3, or 4. ... Ongoing research aims to refine the WHO 2009 ...

  9. Current Dengue Fever Research

    Basic research includes a wide range of studies focused on learning how the dengue virus is transmitted and how it infects cells and causes disease. This type of research investigates many aspects ...

  10. Dengue virus

    Dengue virus is an infectious agent that causes the tropical disease dengue fever in humans. This virus species is transmitted by mosquitoes (arthropods) and thus is an arbovirus. Latest Research ...

  11. Dengue Fever: Causes, Complications, and Vaccine Strategies

    Substances. Dengue Vaccines. Dengue is a highly endemic infectious disease of the tropical countries and is rapidly becoming a global burden. It is caused by any of the 4 serotypes of dengue virus and is transmitted within humans through female Aedes mosquitoes. Dengue disease varies from mild fever to severe conditions of deng ….

  12. Dengue infection

    Dengue (also named 'breakbone disease') is frequently a very painful disease and mainly produces abdominal pain, backache, headache and myalgias 274. By contrast, myositis (muscle inflammation ...

  13. A study on knowledge, attitudes and practices regarding dengue fever

    Background The World Health Organization (WHO) has ranked dengue as one of the top ten threats to Global health in 2019. Sri Lanka faced a massive dengue epidemic in 2017, the largest outbreak in the country during the last three decades, consisting of 186,101 reported cases, and over 320 deaths. The epidemic was controlled by intense measures taken by the health sector. However, the reported ...

  14. Dengue Fever: Causes, Complications, and Vaccine Strategies

    1. Introduction to Dengue (1) Overview.Dengue is an infectious disease caused by any of the four dengue virus serotypes: DENVs 1-4. It is a mosquito-borne disease and is primarily transmitted to humans by the female Aedes mosquito. The disease is mainly concentrated in tropical and subtropical regions, putting nearly a third of the human population, worldwide, at risk of infection [].

  15. Dengue

    Dengue virus (DENV) is responsible for an estimated 100 million symptomatic cases of infection and 10,000 deaths annually. The incidence of dengue has been doubling every decade since 1990.1 Dengue...

  16. Severe disease during both primary and secondary dengue virus ...

    Dengue is a global epidemic causing over 100 million cases annually. The clinical symptoms range from mild fever to severe hemorrhage and shock, including some fatalities. The current paradigm is ...

  17. Risk predictors of progression to severe disease during the febrile

    we divided dengue progression into two groups: individuals who progressed to severe disease (defined as dengue haemorrhagic fever according to 1997 guidelines or severe dengue according to 2009 guidelines) and individuals who did not progress to severe disease (dengue fever and non-severe dengue; appendix pp 5-7). Each risk factor was ...

  18. Clinical Characteristics and Risk Factors for Severe Dengue Fever in

    2 Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases, Kunming, China; 3 Yunnan Key Laboratory of Vector-Borne Infectious Disease, Kunming, ... In 2019, there were 22599 cases of dengue fever, with an incidence rate of 1.63/10 million . As a typical dengue epidemic area, in 2019, the main epidemic type in ...

  19. The current and future global distribution and population at risk of dengue

    We predict that 3.83 (3.45-4.09) billion people (roughly 53% of the global population) live in areas that are suitable for dengue transmission, with the vast majority in Asia, followed by Africa ...

  20. Knowledge, attitude and practice on dengue prevention and dengue

    Dengue fever is a mosquito-borne viral disease caused by a flavivirus. There are four distinct serotypes of dengue virus, namely DEN-1, 2, 3 and 4. ... Research articles News & Comment Collections ...

  21. Risk and predictive factors for severe dengue infection: A ...

    Background Dengue is a major public health issue worldwide and severe dengue (SD) is life threatening. It is critical to triage patients with dengue infection in the early stage. However, there is limited knowledge on early indicators of SD. The objective of this study is to identify risk factors for the prognosis of SD and try to find out some potential predictive factors for SD from dengue ...

  22. Effects of high temperatures and heatwaves on dengue fever: a

    Studies were included if they met the eligibility criteria: (1) peer-reviewed original research articles, (2) quantitative observational time series, case-crossover or case series human studies in the general population with dengue infection cases or incidence as the outcome of interest and (3) the exposures of interest were high temperatures ...

  23. Full article: Regional molecular epidemiology of dengue and the

    Research included almost 16,000 subjects between 2 and 59 years of age, who received one vaccine dose with a placebo comparator. ... Article highlights. Dengue disease represents a large and growing global threat to public health, accounting for a significant burden to health systems of endemic countries. ... Camacho E, et al. Epidemiology and ...

  24. Dengue infection in India: A systematic review and meta-analysis

    Dengue fever had a predominant urban distribution a few decades earlier, but is now also reported from peri-urban as well as rural areas [4,5]. ... Our review also identified certain research gaps in the understanding on dengue epidemiology in the country. There is a need to initiate well planned community-based cohort studies representing ...

  25. Dengue Fever

    Dengue is a mosquito-transmitted virus and is the leading cause of arthropod-borne viral disease worldwide, posing a significant global health concern. This disease is also known by various monikers, such as breakbone or 7-day fever, and is characterized by intense muscle spasms, joint pain, and high fever, reflecting both the severity and the duration of symptoms.